SOURCE: Sunwin International Neutraceuticals, Inc.

January 25, 2006 08:00 ET

Sunwin International Neutraceuticals to Host a Series of Investor Presentations

NEW YORK, NY and QUFU, CHINA -- (MARKET WIRE) -- January 25, 2006 -- Sunwin International Neutraceuticals, Inc. (OTC BB: SUWN), a leader in the production and distribution of Chinese herbs, veterinary medicines and low calorie natural sweetener (Stevia) in China, announced it will host a series of investor conferences to communicate the Company's business strategy, acquisition developments, and growth potential to the investment community. The conferences are part of a campaign launched by the Company in the fourth quarter of 2005. Please visit investor sector at for a full itinerary.

Sunwin Investor Conference Itinerary

--  The World Money Show, February 1-4, 2006, in Orlando, Florida. SUWN
    will host a series of one-on-one meetings, luncheons, and dinner events
    during the week.
--  Investor luncheon - Boca Raton, FL, February 9, 2006, 12pm - 2pm
    (EST), Maggiano's Restaurant, 21090 St. Andrews Blvd, Boca Raton, Florida.
--  Investor luncheon - February 20, 2006 12:30pm - 3:00 pm (PST) at
    Chanticlair Restaurant, 18912 MacArthur Blvd, Newport Beach, California.
--  Roth Capital Micro-Cap Conference, February 20-22, 2006.  SUWN will
    host a series of one-on-one meetings at the St. Regis Monarch Beach Resort
    & Spa, 33000 Niguel Road, Dana Point, CA.
--  Investor luncheon - February 22, 2006, 1pm - 3pm (PST), Mr. Chow's
    Restaurant, 344 N Camden Drive, Beverly Hills, California.
All shareholders and prospective investors are welcome. Please RSVP at

Mr. Alan Stone, Managing Director of ASC, stated, "We have arranged a comprehensive program for SUWN representatives to meet with a wide range of market professionals. Our goal is to present the Company's exciting accomplishments and growth opportunities to the broader investment community. Demand for Chinese related securities remains strong; we believe that the planned events and activities will improve the Company's visibility on Wall Street, broaden its shareholder base, increase the stock's trading liquidity and enhance long-run shareholder value."

About Sunwin International Neutraceuticals, Inc.

Sunwin International Neutraceuticals, Inc. (OTC BB: SUWN) is engaged in the areas of essential traditional Chinese medicine, 100% organic herbal medicine, neutraceutical products, natural sweetener (Stevia), and veterinary medicines and feeds prepared from 100% organic herbal ingredients. As an industry leader in agricultural processing, Sunwin has built an integrated global firm with the sourcing and production capabilities to meet the needs of consumers throughout the world. Sunwin also makes such value-added products as specialty veterinary food ingredients and specialty feed ingredients. The Sunwin family works closely with consumers to provide a quality and a hybrid mix of agricultural products and services that meet growing demand. In 2002, Sunwin was recognized as one of the first 2,000 state-level companies that China authorized as the most important innovative high-tech pioneer businesses by the Chinese central government. In 2002, Sunwin was awarded as one of 2002 state-level biological product manufacturers in China. In 2003, Sunwin ranked as one of the top 50 companies of China Animal Related Health Care Product Pharmaceutical Industry. In 2003, Sunwin received the award of Shandong Top-Ten Innovative, High-Tech Businesses by the Province Government of Shandong. For more info about Sunwin, please visit

Safe Harbor Statement

Certain of the statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate," "project," "intend," "forecast," "anticipate," "plan," "planning," "expect," "believe," "will likely," "should," "could," "would," "may" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted, and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited financial resources, domestic or global economic conditions -- especially those relating to China, activities of competitors and the presence of new or additional competition, and changes in Federal or State laws, restrictions and regulations on doing business in a foreign country, in particular China, and conditions of equity markets. More information about the potential factors that could affect the Company's business and financial results is included in the Company's filings, available via the United States Securities and Exchange Commission.

Contact Information